llms.txt
Compare with other sites' llms.txt files →# Orchid Pharma
> Orchid Pharma is an integrated Indian pharmaceutical company developing novel anti-infectives, manufacturing active ingredients and finished formulations, and supporting antimicrobial stewardship for healthcare systems, pharmaceutical partners, hospitals, and patients across more than 70 countries.
## Main
- [Home](https://www.orchidpharma.com): Overview of Orchid Pharma’s integrated pharmaceutical capabilities, global reach, regulatory credentials, manufacturing facilities, novel medicines, stewardship programs, and healthcare partnerships.
- [About Orchid Pharma](https://www.orchidpharma.com/about): Company history since 1992, leadership, scientific mission, global partnerships, regulatory standards, manufacturing infrastructure, and commitment to expanding access to essential medicines.
- [Contact Orchid Pharma](https://www.orchidpharma.com/contact): General inquiry form and dedicated email channels for API sourcing, formulation requirements, Enmetazobactam licensing, commercial collaborations, and investor relations.
## Services
- [API Manufacturing](https://www.orchidpharma.com/api-manufacturing): Searchable portfolio of cephalosporin and non-cephalosporin active pharmaceutical ingredients supported by backward integration, sterile manufacturing, and international regulatory approvals.
- [Formulations Manufacturing](https://www.orchidpharma.com/formulations): Integrated manufacturing solutions for sterile injectables, oral formulations, branded generics, and patient-ready therapies supplied to regulated and emerging markets.
- [Novel Medicines](https://www.orchidpharma.com/novel-medicines): Clinical evidence, treatment applications, differentiation, and approval information for Orchid Pharma’s therapies targeting resistant Gram-positive and Gram-negative infections.
- [Research and Development](https://www.orchidpharma.com/research-development): Research capabilities spanning process engineering, non-infringing synthetic routes, NCE discovery, peptide synthesis, sustainable manufacturing, patents, and CDMO partnership models.
- [EXBLIFEP® / ORBLICEF™](https://www.orchidpharma.com/exblifep-r-orblicef-tm): Scientific background, development timeline, clinical purpose, and global impact of the cefepime and Enmetazobactam combination for drug-resistant bacterial infections.
## Contact
- Email (Global Partnerships & Licensing): EXBLIFEP@orchidpharma.com
- Email (Supply Chain & API Sales): api@orchidpharma.com
- Email (Investor Relations): investorrelations@orchidpharma.com
- Email (Formulations): Formulations@orchidpharma.com
- LinkedIn: https://www.linkedin.com/company/orchid-pharma/
- Instagram: https://www.instagram.com/orchidpharma/
- Facebook: https://www.facebook.com/people/Orchid-Pharma/61577068756600/?_rdr
- YouTube: https://www.youtube.com/@OrchidPharma